Support For Small Companies In AMR Space Is Crucial Now
Executive Summary
G7 countries should look to US PASTEUR Act For Inspiration On Pull Incentives for Antimicrobials
You may also be interested in...
French Consortium Pioneers New AMR Development Model
A new consortium that has won funding from the French government will focus on developing new treatments, diagnostics and surveillance and make sure that these approaches are properly valued by involving health economists in new drug development.
US PASTEUR Act Promises More Than Other National AMR Initiatives
PASTEUR Act in the US is the most promising initiative out there to address antimicrobial resistance.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.